Invention Grant
- Patent Title: Morpholine compound
- Patent Title (中): 吗啉化合物
-
Application No.: US11662228Application Date: 2005-09-08
-
Publication No.: US07935700B2Publication Date: 2011-05-03
- Inventor: Yoshihito Tanaka , Shuzo Takeda , Hidemitsu Higashi , Mamoru Matsuura , Fujio Kobayashi , Maiko Hamada , Minoru Tanaka
- Applicant: Yoshihito Tanaka , Shuzo Takeda , Hidemitsu Higashi , Mamoru Matsuura , Fujio Kobayashi , Maiko Hamada , Minoru Tanaka
- Applicant Address: JP Osaka
- Assignee: Mitsubishi Tanabe Pharma Corporation
- Current Assignee: Mitsubishi Tanabe Pharma Corporation
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2004-261655 20040908
- International Application: PCT/JP2005/017002 WO 20050908
- International Announcement: WO2006/028284 WO 20060316
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D417/12
Abstract:
A compound represented by the formula (1) wherein ring A is aryl optionally having substituent(s) and the like; ring B is arylene optionally having substituent(s) and the like; m=0-2; n=1-5; X is a bond and the like; Y is a bond and the like; and Z is hydrogen atom and the like or a pharmaceutically acceptable salt thereof, and a hydrate or solvate thereof have affinity for CCR3, and can be pharmaceutical products for the treatment and/or prophylaxis of immune or inflammatory diseases.
Public/Granted literature
- US20070265257A1 Morpholine Compound Public/Granted day:2007-11-15
Information query
